Edwards Lifesciences (EW) Return on Capital Employed (2010 - 2026)

Edwards Lifesciences' Return on Capital Employed history runs 17 years deep, the most recent figure standing at 11.13% for Q1 2026.

• In Q1 2026, Return on Capital Employed fell 110.0% year-over-year to 11.13%; the TTM figure through Mar 2026 stood at 11.13% (down 110.0% YoY), while the FY2025 annual figure was 10.93%, down 327.0% from the prior year.
• Return on Capital Employed was 11.13% for Q1 2026 at Edwards Lifesciences, up from 10.83% in the prior quarter.
• In the past five years, Return on Capital Employed ranged from a high of 23.24% in Q1 2022 to a low of 10.83% in Q4 2025.
• Historically, Return on Capital Employed has averaged 16.07% across 5 years, with a median of 15.7% in 2024.
• The sharpest annual moves came in 2022 and 2023: Return on Capital Employed surged 888 bps in 2022, then plunged 671 bps in 2023.
• A 5-year view of Return on Capital Employed shows it stood at 20.13% in 2022, then declined by 17 bps to 16.7% in 2023, then dropped by 28 bps to 11.98% in 2024, then dropped by 10 bps to 10.83% in 2025, then advanced by 3 bps to 11.13% in 2026.
• The last three Return on Capital Employed figures came in at 11.13% (Q1 2026), 10.83% (Q4 2025), and 12.09% (Q3 2025), per Business Quant data.